Seroprevalence of 13 common pathogens in a rapidly growing U.S. minority population: Mexican Americans from San Antonio, TX

BMC Research Notes

Volumn 4, Issue , 2011, Pages

  Rubicz, Rohina ^a   Leach, Charles T ^b   Kraig, Ellen ^b   Dhurandhar, Nikhil V ^c   Grubbs, Barry ^b   Blangero, John ^a   Yolken, Robert ^d   Göring, Harald Hh ^a  

^a SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRIDAE; CHLAMYDOPHILA PNEUMONIAE; CYTOMEGALOVIRUS; HELICOBACTER PYLORI; HEPATITIS A VIRUS; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 3; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 6; SIMPLEXVIRUS; TOXOPLASMA GONDII;

EID: 80054737071     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-4-433     Document Type: Article

References (64)

1. Incidence of herpes simplex virus type 2 infection in the United States. Armstrong GL, Schillinger J, Markowitz L, Nahmias AJ, Johnson RE, McQuillan GM, St Louis ME, Am J Epidemiol 2001 153 912 920 10.1093/aje/153.9.912 11323323 (Pubitemid 32378626)
2. Cytomegalovirus seroprevalence in the United States: The National Health and Nutrition Examination Surveys, 1988-2004. Bate SL, Dollard SC, Cannon MJ, Clin Infect Dis 2010 50 1439 47 10.1086/652438 20426575
3. Toxoplasma gondii infection in the United States, 1999-2004, decline from the prior decade. Jones JL, Kruszon-Moran D, Sanders-Lewis K, Wilson M, Am J Trop Med Hyg 2007 77 405 410 17827351 (Pubitemid 351844310)
4. Human herpesvirus-6: Clinical implications of a recently discovered, ubiquitous agent. Leach CT, Sumaya CV, Brown NA, J Pediatr 1992 121 173 181 10.1016/S0022-3476(05)81184-9 1322455
5. Helicobacter pylori infection in preschool and school-aged minority children: Effect of socioeconomic indicators and breast-feeding practices. Malaty HM, Logan ND, Graham DY, Ramchatesingh JE, Clin Infect Dis 2001 32 1387 1392 10.1086/320148 11317237 (Pubitemid 32424270)
6. Socioeconomic and race/ethnic patterns in persistent infection burden among U.S. adults. Zajacova A, Dowd JB, Aiello AE, J Gerontol A Biol Sci Med Sci 2009 64 272 279 19196638
7. Socioeconomic differentials in immune response. Dowd JB, Aiello AE, Epidemiology 2009 20 902 908 10.1097/EDE.0b013e3181bb5302 19797966
8. Geographical differences in autoantibodies and anti-infectious agents antibodies among healthy adults. Shapira Y, Katz BS, Gilburd B, Barzilai O, Ram M, Blank M, Lindeberg S, Frostegard J, Anaya J-M, Bizzaro N, Jara LJ, Damoiseaux J, Shoenfeld Y, Levin NA, Clin Rev Allerg Immunol 2011 Epub
9. Autoimmunity, infectious immunity, and atherosclerosis. Matsuura E, Kobayashi K, Matsunami Y, Shen L, Quan N, Makarova M, Suchkov SV, Ayada K, Oguma K, Lopez LR, J Clin Immunol 2009 29 714 721 10.1007/s10875-009-9333-5 19795194
10. Infectious serology and atherosclerosis: How burdensome is the risk? Muhlestein JB, Anderson JL, Circulation 2003 107 220 222 10.1161/01.CIR. 0000043909.78380.A0 12538417 (Pubitemid 36135213)
11. Prospective study of pathogen burden and risk of myocardial infarction or death. Zhu J, Nieto FJ, Horne BD, Anderson JL, Muhlestein JB, Epstein SE, Circulation 2001 103 45 51 11136684 (Pubitemid 32050434)
12. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieman MS, Makela PH, Huttunen JK, Valtonen V, Lancet 1988 2 983 986 2902492
13. Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease. Mendall MA, Carrington D, Strachan D, Patel P, Molineaux N, Levi J, Toosey T, Camm AJ, Northfield TC, J Infect 1995 30 121 128 10.1016/S0163-4453(95)80006-9 7636277
14. Helicobacter pylori, Chlamydia pneumoniae and myocardial infarction. Fraser AG, Scragg RK, Cox B, Jackson RT, Intern Med J 2003 33 267 272 10.1046/j.1445-5994.2003.00349.x 12823670
15. A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease: the atherosclerosis risk in communities (ARIC) study. Sorlie PD, Nieto FJ, Adam E, Folsom AR, Shahar E, Massing M, Arch Intern Med 2000 160 2027 2032 10.1001/archinte.160.13.2027 10888976 (Pubitemid 30437586)
16. Hepatitis A virus infection and atherosclerosis. Zhu J, Epstein SE, J Infect Dis 2001 184 390 391 11443571 (Pubitemid 32662192)
17. Herpesvirus (HSV-1, EBV and CMV) infections in atherosclerotic compared with non-atherosclerotic aortic tissue. Shi Y, Tokunaga O, Pathol Int 2002 52 31 39 10.1046/j.1440-1827.2002.01312.x 11940204 (Pubitemid 34299211)
18. Impact of pathogen burden in patients with coronary artery disease in relation to systemic inflammation and variation in genes encoding cytokines. Georges JL, Rupprecht HJ, Blankenberg S, Poirier O, Bickel C, Hafner G, Nicaud V, Meyer J, Camien F, Tiret L, AtheroGene Group, Am J Cardiol 2003 92 515 521 10.1016/S0002-9149(03)00717-3 12943869 (Pubitemid 37013401)
19. Impact of infectious burden on progression of carotid atherosclerosis. Espinola-Klein C, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, Hafner G, Prellwitz W, Schlumberger W, Meyer J, Stroke 2002 33 2581 2586 10.1161/01.STR.0000034789.82859.A4 12411646 (Pubitemid 35266427)
20. Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Rupprecht HJ, Blankenberg S, Bickel C, Hafner G, Prellwitz W, Schlumberger W, Meyer J, AutoGene Investigators, Circulation 2001 104 25 31 10.1161/hc2601.091703 11435333 (Pubitemid 32623285)
21. Prospective study of pathogen burden and risk of myocardial infarction or death. Zhu J, Nieto FJ, Horne BD, Anderson JL, Muhlestein JB, Epstein SE, Circulation 2001 103 45 51 11136684 (Pubitemid 32050434)
22. Leading health indicators: A comparison of Hispanics with non-Hispanic Whites and non-Hispanic Blacks, United States 2003. Chowdhury PP, Balluz L, Okoro C, Strine T, Ethn Dis 2006 16 534 541 17682283 (Pubitemid 46952657)
23. U.S. Hispanic population surpasses 45 million, now 15 percent of total. Berenstein R, U.S. Census Bureau News 2008
24. Genetic and environmental contributions to cardiovascular risk factors in Mexican Americans, The San Antonio Family Heart Study. Mitchell BD, Kammerer CM, Blangero J, Mahaney MC, Rainwater DL, Dyke B, Hixson JE, Henkel RD, Sharp RM, Comuzzie AG, VandeBerg JL, Stern MP, MacCluer JW, Circulation 1996 94 2159 2170 8901667 (Pubitemid 26360509)
25. A novel system for storage of sera frozen in small aliquots. Cheng ML, Woodford SC, Hilburn JL, VandeBerg JL, J Biochem Biophys Methods 1986 13 47 51 10.1016/0165-022X(86)90007-2 3772018 (Pubitemid 16037353)
26. Increased adiposity in animals due to a human virus. Dhurandhar NV, Israel BA, Kolesar JM, Mayhew GF, Cook ME, Atkinson RL, Int J Obes Relat Metab Disord 2000 24 989 996 10.1038/sj.ijo.0801319 10951537 (Pubitemid 30618118)
27. Multipoint quantitative-trait linkage analysis in general pedigrees. Almasy L, Blangero J, Am J Hum Genet 1998 62 1198 1211 10.1086/301844 9545414 (Pubitemid 28199022)
28. Extensions to pedigree analysis. III. Variance components by the scoring method. Lange K, Westlake J, Spence MA, Ann Hum Genet 1976 39 485 491 10.1111/j.1469-1809.1976.tb00156.x 952492
29. A variance component approach to dichotomous trait linkage analysis using a threshold model. Duggirala R, Williams JT, Williams-Blangero S, Blangero J, Genet Epidemiol 1997 14 987 992 10.1002/(SICI)1098-2272(1997)14:6<987::AID- GEPI71>3.0.CO;2-G 9433612 (Pubitemid 28027521)
30. Rectangular confidence region for the means of multivariate normal distributions. Sidk Z, J Am Stat Assoc 1967 62 626 633 10.2307/2283989
31. Prevalence and persistence of antibodies to herpes viruses, Chlamydia pneumoniae and Helicobacter pylori in Alaskan Eskimos: The GOCADAN study. Zhu J, Davidson M, Leinonen M, Saikku P, Gaydos CA, Canos DA, Gutman KA, Howard BV, Epstein SE, Clin Microbiol Infect 2006 12 118 122 10.1111/j.1469-0691.2005. 01319.x 16441448 (Pubitemid 43379338)
32. Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture. Hyman CL, Roblin PM, Gaydos CA, Quinn TC, Schachter J, Hammerschlag MR, Clin Infect Dis 1995 20 1174 1178 10.1093/clinids/20.5.1174 7619996
33. Racial and ethnic differences in the seroprevalence of 6 infectious diseases in the United States: Data from NHANES III, 1988-1994. McQuillan GM, Kruszon-Moran D, Kottiri BJ, Curtin LR, Lucas JW, Kington RS, Am J Public Health 2004 94 1952 1958 10.2105/AJPH.94.11.1952 15514236 (Pubitemid 39434829)
34. Prevalence of antibodies to EB virus and other herpesviruses. Porter DD, Wimberly I, Benyesh-Melnick M, JAMA 1969 208 1675 1679 10.1001/jama.208.9.1675 4305626
35. Seroepidemiology of EBV and interpretation of the "isolated VCA IgG" pattern. De Paschale M, Agrappi C, Manco MT, Agrappi C, Manco MT, Mirri P, Vigano EF, Clerici P, J Med Virol 2009 81 325 331 10.1002/jmv.21373 19107979
36. Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids. Atkinson RL, Dhurandhar NV, Allison DB, Bowen RL, Israel BA, Albu JB, Augustus AS, Int J Obes 2005 29 281 286 10.1038/sj.ijo.0802830 (Pubitemid 40333226)
37. Association between human adenovirus-36 and lipid disorders in Korean schoolchildren. Na HN, Hong Y-M, Kim J, Kim H-K, Jo I, Nam J-H, Int J Obes 2010 34 89 93 10.1038/ijo.2009.207
38. Adenovirus-36 infection and obesity in children and adolescents. Gabbert CC, Schwimmer AJ, Obesity 2009 17 60 10.1038/oby.2008.469 (Pubitemid 50310542)
39. Human obesity relationship with Ad36 adenovirus and insulin resistance. Trovato GM, Castro A, Tonzuso A, Garozzo A, Martines GF, Pirri C, Trovato F, Catalano D, Int J Obes 2009 33 1402 1409 10.1038/ijo.2009.196
40. Adenovirus 36 seropositivity is strongly associated with race and gender, but not obesity, among US military personnel. Broderick MP, Hansen CJ, Irvine M, Metzgar D, Campbell K, Baker C, Russell KL, Int J Obes 2010 34 302 308 10.1038/ijo.2009.224
41. The epidemiology of viral hepatitis in children in south Texas: Increased prevalence of hepatitis A along the Texas-Mexico border. Leach CT, Koo FC, Hilsenbeck SG, Jenson HB, J Infect Dis 1999 180 509 513 10.1086/314861 10395871 (Pubitemid 30256337)
42. Hepatitis A virus infection in the United States: Serologic results from the third national health and nutrition examination survey. Bell BP, Kruszon-Moran D, Shapiro CN, Lambert SB, McQuillan GM, Margolis HS, Vaccine 2005 23 5798 5806 10.1016/j.vaccine.2005.03.060 16307834 (Pubitemid 41668887)
43. Hepatitis A vaccination coverage among children aged 24-35 months - United States, 2004-2005. Centers for Disease Control and Prevention (CDC), Morb Mortal Wkly Rep 2007 56 678 681
44. Helicobacter in the developing World. Frenck RW, Clemens J, Microbes Infect 2003 5 705 713 10.1016/S1286-4579(03)00112-6 12814771 (Pubitemid 36695145)
45. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: A global review. Smith JS, Robinson NJ, J Infect Dis 2002 186 Suppl 1 3 S28 12353183
46. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. Xu F, Sternberg MR, Kottiri BJ, McQuillan GM, Lee FK, Nahmias AJ, Berman SM, Markowitz LE, JAMA 2006 296 964 973 10.1001/jama.296.8.964 16926356 (Pubitemid 44285373)
47. Fall in human herpesvirus 6 seropositivity with age. Brown NA, Sumaya CV, Liu CR, Ench Y, Kovacs A, Coronesi M, Kaplan MH, Lancet 1988 2 396 2899800
48. High prevalence of antibody titer to human herpesvirus-6 and decrease in titer with increase in age in Japan. Yanagi K, Harada S, Ban F, Oya A, Okabe N, Tobinai K, JID 1990 161 153 154 1688600 (Pubitemid 20021882)
49. Toxoplasma gondii infection in the United States, 1999-2000. Jones JL, Kruszon-Moran D, Wilson M, Emerg Infect Dis 2003 9 1371 1374 14718078 (Pubitemid 37356207)
50. Sex difference in the effects of sociocultural status on diabetes and cardiovascular risk factors in Mexican Americans: The San Antonio Heart Study. Stern MP, Rosenthal M, Haffner SM, Hazuda HP, Franco LJ, Am J Epidemiol 1984 120 834 851 6507426 (Pubitemid 15216798)
51. Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans. Duggirala R, Blangero J, Almasy L, Dyer TD, Williams KL, Leach RJ, O'Connell P, Stern MP, Am J Hum Genet 1999 64 1127 1140 10.1086/302316 10090898 (Pubitemid 30463044)
52. Genome-wide linkage analyses of type 2 diabetes in Mexican Americans, The San Antonio Family Diabetes/Gallbladder Study. Hunt KJ, Lehman DM, Arya R, Fowler S, Leach RJ, Göring HHH, Almasy L, Blangero J, Dyer TD, Duggirala R, Stern MP, Diabetes 2005 54 2655 2662 10.2337/diabetes.54.9.2655 16123354 (Pubitemid 41233587)
53. A genomewide search finds major susceptibility loci for gallbladder disease on chromosome 1 in Mexican Americans. Puppala S, Dodd GD, Fowler S, Arya R, Schneider J, Farook VS, Granato R, Dyer TD, Almasy L, Jenkinson CP, Diehl AK, Stern MP, Blangero J, Duggirala R, Am J Hum Genet 2006 78 377 392 10.1086/500274 16400619 (Pubitemid 43291221)
54. Regulation of cellular immunity prevents Helicobacter pylori-induced atherosclerosis. Ayada K, Yokota K, Hirai K, Fujimoto K, Kobayashi K, Ogawa H, Hatanaka K, Hirohata S, Yoshino T, Shoenfeld Y, Matsuura E, Oguma K, Lupus 2009 18 1154 1168 10.1177/0961203309106600 19880562
55. Herpes simplex virus 1 induced LOX-1 expression in an endothelial cell line, ECV 304. Chirathaworn C, Pongpanich A, Poovorawan Y, Viral Immunol 2004 17 308 314 10.1089/0882824041310531 15279708 (Pubitemid 38880430)
56. Synergistic effect of persistent Chlamydia pneumoniae infection, autoimmunity, and inflammation on coronary risk. Huittinen T, Leinonen M, Tenkanen L, Virkkunen H, Manttari M, Palosuo T, Manninen V, Saikku P, Circulation 2003 107 2566 2570 10.1161/01.CIR.0000068338.17948.22 12743003 (Pubitemid 36628937)
57. Increased risk of atherosclerosis is confined to CagA-positive Helicobacter pylori strains: Prospective results from the Bruneck Study. Mayr M, Kiechl S, Mendall MA, Willeit J, Wick G, Xu Q, Stroke 2003 34 610 615 10.1161/01.STR.0000058481.82639.EF 12624280 (Pubitemid 36307380)
58. Mechanisms of cytomegalovirus-accelerated vascular disease: Induction of paracrine factors that promote angiogenesis and wound healing. Streblow DN, Dumortier J, Moses AV, Orloff SL, Nelson JA, Curr Top Microbiol Immunol 2008 325 397 415 10.1007/978-3-540-77349-8-22 18637518
59. The possible role of hepatitis A virus in the pathogenesis of atherosclerosis. Zhu J, Quyyumi AA, Norman JE, Costello R, Csako G, Epstein SE, J Infect Dis 2000 182 1583 1587 10.1086/317613 11069227
60. Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Espinola-Klein C, Rupprecht HJ, Blankenberg S, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, Rippin G, Victor A, Hafner G, Schlumberger W, Meyer J, Circulation 2002 105 15 21 10.1161/hc0102.101362 11772870 (Pubitemid 34049136)
61. Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. Zhu J, Quyyumi AA, Norman JE, Csako G, Waclawiw MA, Shearer GM, Epstein SE, Am J Cardiol 2000 85 140 146 10.1016/S0002-9149(99) 00653-0 10955367 (Pubitemid 30026092)
62. Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. Everhart JE, Kruszon-Moran D, Perez-Perez GI, Tralka TS, McQuillan G, J Infect Dis 2000 181 1359 1363 10.1086/315384 10762567 (Pubitemid 30252540)
63. Human herpesvirus type 6: Review. Oren I, Sobel JD, Clin Infect Dis 1992 14 741 746 10.1093/clinids/14.3.741 1314102
64. Varicella in Americans from NHANES III: Implications for control through routine immunization. Kilgore PE, Kruszon-Moran D, Seward JF, Jumaan A, Van Loon FP, Forghani B, McQuillan GM, Wharton M, Fehrs LJ, Cossen CK, Hadler SC, J Med Virol 2003 70 Suppl 1 111 S118 12627498